Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Connelly

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|February 19, 2022
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic TransplantationAmeet Patel, Karina Wilkerson, Heidi Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Pediatric Transplantation|November 19, 2015
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipientsCameron L Jordan, David J Taber, Maggee O Kyle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
The Lancet. Haematology|December 28, 2019
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort studyKasiani C Myers, Elissa Furutani, Edie Weller, et al.
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|February 19, 2022
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic TransplantationAmeet Patel, Karina Wilkerson, Heidi Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Orphanet Journal of Rare Diseases|April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Pediatric Transplantation|November 19, 2015
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipientsCameron L Jordan, David J Taber, Maggee O Kyle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
The Lancet. Haematology|December 28, 2019
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort studyKasiani C Myers, Elissa Furutani, Edie Weller, et al.
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Pageof 4